Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive eslicarbazepine acetate for refractory partial seizures (KCT0000360)
KCT0000360Phase 3Completed
- Sponsor
- BIAL
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eslicarbazepine acetate in Focal Onset Epilepsy, sponsored by BIAL. Started May 2011; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on KCT0000360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000360.